Boston Scientific Expands Peripheral Footprint With Buy From Bayer
This article was originally published in The Gray Sheet
Executive Summary
Boston picks up Bayer Healthcare’s interventional unit, while Bayer pledges to put more focus on the radiology and diabetes care segments of its medical care division.